145 related articles for article (PubMed ID: 2530765)
21. Plasma ratio tryptophan/neutral amino acids in relation to clinical response to paroxetine and clomipramine in patients with major depression.
Møller SE; Bech P; Bjerrum H; Bøjholm S; Butler B; Folker H; Gram LF; Larsen JK; Lauritzen L; Loldrup D
J Affect Disord; 1990 Jan; 18(1):59-66. PubMed ID: 2136870
[TBL] [Abstract][Full Text] [Related]
22. A double-blind comparison of paroxetine, imipramine, and placebo in major depression.
Shrivastava RK; Shrivastava SH; Overweg N; Blumhardt CL
J Clin Psychiatry; 1992 Feb; 53 Suppl():48-51. PubMed ID: 1531825
[TBL] [Abstract][Full Text] [Related]
23. New antidepressants and 5-HT uptake inhibitors.
Montgomery SA
Acta Psychiatr Scand Suppl; 1989; 350():107-16. PubMed ID: 2530760
[TBL] [Abstract][Full Text] [Related]
24. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
Fabre LF
J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
[TBL] [Abstract][Full Text] [Related]
25. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.
Dunner DL; Cohn JB; Walshe T; Cohn CK; Feighner JP; Fieve RR; Halikas JP; Hartford JT; Hearst ED; Settle EC
J Clin Psychiatry; 1992 Feb; 53 Suppl():57-60. PubMed ID: 1531827
[TBL] [Abstract][Full Text] [Related]
26. Paroxetine plasma levels: lack of correlation with efficacy or adverse events.
Tasker TC; Kaye CM; Zussman BD; Link CG
Acta Psychiatr Scand Suppl; 1989; 350():152-5. PubMed ID: 2530776
[No Abstract] [Full Text] [Related]
27. Therapeutic effects of fengabine, a new GABAergic agent, in depressed outpatients: a double-blind study versus clomipramine.
Nielsen NP; Cesana B; Zizolfi S; Ascalone V; Priore P; Morselli PL
Acta Psychiatr Scand; 1990 Nov; 82(5):366-71. PubMed ID: 2281807
[TBL] [Abstract][Full Text] [Related]
28. Paroxetine: pharmacokinetic and antidepressant effect in the elderly.
Lundmark J; Scheel Thomsen I; Fjord-Larsen T; Manniche PM; Mengel H; Møller-Nielsen EM; Pauser H; Wålinder J
Acta Psychiatr Scand Suppl; 1989; 350():76-80. PubMed ID: 2530794
[TBL] [Abstract][Full Text] [Related]
29. Paroxetine in the treatment of depression--a randomized comparison with amitriptyline.
Laursen AL; Mikkelsen PL; Rasmussen S; le Fèvre Honoré P
Acta Psychiatr Scand; 1985 Mar; 71(3):249-55. PubMed ID: 3157296
[TBL] [Abstract][Full Text] [Related]
30. A controlled double-blind study of femoxetine and amitriptyline in patients with endogenous depression.
Reebye PN; Yiptong C; Samsoon J; Schulsinger F; Fabricius J
Pharmacopsychiatria; 1982 Sep; 15(5):164-9. PubMed ID: 6757983
[TBL] [Abstract][Full Text] [Related]
31. A placebo- and imipramine-controlled study of paroxetine.
Cohn JB; Crowder JE; Wilcox CS; Ryan PJ
Psychopharmacol Bull; 1990; 26(2):185-9. PubMed ID: 2146697
[TBL] [Abstract][Full Text] [Related]
32. Antidepressants and the peripheral nervous system.
Husstedt IW; Kuhs H; Rudolf GA; Brune GG
Acta Psychiatr Scand Suppl; 1989; 350():147-8. PubMed ID: 2530774
[No Abstract] [Full Text] [Related]
33. The short- and long-term efficacy of paroxetine HCl: B. Data from a double-blind crossover study and from a year-long term trial vs. imipramine and placebo.
Peselow ED; Filippi AM; Goodnick P; Barouche F; Fieve RR
Psychopharmacol Bull; 1989; 25(2):272-6. PubMed ID: 2532374
[No Abstract] [Full Text] [Related]
34. Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients.
Möller HJ; Berzewski H; Eckmann F; Gonzalves N; Kissling W; Knorr W; Ressler P; Rudolf GA; Steinmeyer EM; Magyar I
Pharmacopsychiatry; 1993 May; 26(3):75-8. PubMed ID: 8415897
[TBL] [Abstract][Full Text] [Related]
35. A pharmacokinetic dose titration study in adult and elderly depressed patients.
Hebenstreit GF; Fellerer K; Zöchling R; Zentz A; Dunbar GC
Acta Psychiatr Scand Suppl; 1989; 350():81-4. PubMed ID: 2530795
[No Abstract] [Full Text] [Related]
36. A placebo-controlled trial of paroxetine in the treatment of major depression.
Smith WT; Glaudin V
J Clin Psychiatry; 1992 Feb; 53 Suppl():36-9. PubMed ID: 1531822
[TBL] [Abstract][Full Text] [Related]
37. Introduction to the development of paroxetine, a novel antidepressant.
Lassen JB
Acta Psychiatr Scand Suppl; 1989; 350():13. PubMed ID: 2530764
[No Abstract] [Full Text] [Related]
38. Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin.
Mertens C; Pintens H
Acta Psychiatr Scand; 1988 Jun; 77(6):683-8. PubMed ID: 2970203
[TBL] [Abstract][Full Text] [Related]
39. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.
Ravindran AV; Judge R; Hunter BN; Bray J; Morton NH
J Clin Psychiatry; 1997 Mar; 58(3):112-8. PubMed ID: 9108813
[TBL] [Abstract][Full Text] [Related]
40. Sociotropy and autonomy: relationship to antidepressant drug treatment response and endogenous-nonendogenous dichotomy.
Peselow ED; Robins CJ; Sanfilipo MP; Block P; Fieve RR
J Abnorm Psychol; 1992 Aug; 101(3):479-86. PubMed ID: 1386856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
